A cross-sectional survey of voriconazole prescribers: Assessing current practice and knowledge of cutaneous side effects. J Am Acad Dermatol 2017 Oct;77(4):769-770
Date
09/18/2017Pubmed ID
28917461DOI
10.1016/j.jaad.2017.04.1136Scopus ID
2-s2.0-85031730707 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Chansky PB, Wanat K, Pappas-Taffer L, Rosenbach M, Micheletti RGAuthor
Karolyn A. Wanat MD Chair, Professor in the Dermatology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antifungal AgentsAttitude of Health Personnel
Cross-Sectional Studies
Drug Eruptions
Drug Utilization
Female
Humans
Incidence
Male
Practice Patterns, Physicians'
Prognosis
Risk Assessment
Skin Neoplasms
Voriconazole